MYDA Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-87,500	Closed	-$730K	–	172
2024 Q3	$730K	Sell	87,500 -52,500	-38%	-$438K	0.16%	81
2024 Q2	$953K	Hold	140,000	–	–	0.21%	56
2024 Q1	$918K	Sell	140,000 -2,383	-2%	-$15.6K	0.26%	62
2023 Q4	$924K	Buy	+142,383	New	+$924K	0.31%	45